BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7563976)

  • 1. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
    Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
    Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor.
    Nicholson AC; Pomerantz KB; Fujimori T; Hajjar DP
    Lipids; 1995 Aug; 30(8):771-4. PubMed ID: 7475994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
    Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
    Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits.
    Tanaka H; Ohtsuka I; Kogushi M; Kimura T; Fujimori T; Saeki T; Hayashi K; Kobayashi H; Yamada T; Hiyoshi H
    Atherosclerosis; 1994 Jun; 107(2):187-201. PubMed ID: 7980693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
    Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
    Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of oleate-rich cholesteryl esters by acetyl-LDL in macrophages in the presence of an acyl-CoA: cholesterol acyltransferase inhibitor (Sandoz 58-035).
    Shimasaki O; Mineo C; Mowri H; Ohkuma S; Takano T
    Biochem Int; 1990; 20(2):389-96. PubMed ID: 2317217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
    Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
    Graham A; Wood JL; Russell LJ
    Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages.
    Mathur SN; Albright E; Field FJ
    Biochem J; 1988 Dec; 256(3):807-14. PubMed ID: 3223954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages.
    Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin inhibits the accumulation of re-esterified cholesterol in macrophages loaded with acetylated low-density lipoprotein.
    Yoshinari M; Yamamoto M; Iino K; Iwase M; Fujishima M
    Biochim Biophys Acta; 1995 Nov; 1259(2):155-60. PubMed ID: 7488635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FCE 27677: a novel inhibitor of acyl-CoA: cholesterol acyltransferase with potent oral hypolipidemic activity.
    Chiari A; Lovisolo P; Radice A; Giorgini L; Fancelli D; Severino D; Ghiselli G
    Pharmacol Res; 1995 Oct; 32(4):189-99. PubMed ID: 8866834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
    Matsui Y; Horiuchi K; Yamamoto K; Kanai K
    Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
    Harte RA; Yeaman SJ; Jackson B; Suckling KE
    Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics.
    Tomoda H; Huang XH; Cao J; Nishida H; Nagao R; Okuda S; Tanaka H; Omura S; Arai H; Inoue K
    J Antibiot (Tokyo); 1992 Oct; 45(10):1626-32. PubMed ID: 1473990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acaterin, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Pseudomonas sp. A92.
    Naganuma S; Sakai K; Hasumi K; Endo A
    J Antibiot (Tokyo); 1992 Aug; 45(8):1216-21. PubMed ID: 1399841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.